Intracellular dynamics and fate of a humanized anti-interleukin-6 receptor monoclonal antibody, Tocilizumab (TCZ) t Hl:::m>1 /?7 -o ..{ q:-/-6~~1*~J:7 o-7;vm1* ( t--/ 9 ;:;(-y 7") O)~Jl §i7'.J llJ~ Pharmaceutical Cell Biology 3PS09015K Keiko Fujimoto [INTRODUCTION) Interleukine-6 (IL-6) is a pleiotropic cytokine that is involved in inflammation, acute phase responses, immune responses, and hematopoiesis (1). These biological functions ofIL-6 are mediated by binding to the IL-6 receptor (IL-6R) system composed of two type-I membrane glycoproteins: a non-signaling and ligand-binding a -receptor IL-6R, which also exists as a soluble form (slL-6R), and a signal transducer protein gpl30. IL-6 first binds to mIL-6R on the cell surface or sIL-6R circulating in body fluids, and then associates with gp130, inducing homodimerization of gpl30 and subsequent activation of the JAK/STAT, ERK and PBK signal transduction pathways (1 , 2) . Deregulated overproduction of IL-6, therefore, is associated with autoimmune and inflammatory diseases including rheumatoid arthritis, juvenile idiopathic arthritis, Crohn 's disease, and Castleman's disease. min, PB-TCZ was significantly reduced from the cell surface and was simultaneously visible in small punctate structures dispersed throughout the cytoplasm. These vesicles exhibited a tendency to accumulate around the perinuclear region with increasing chase periods and the rate of colocalization between IL-6R-GFP and PB-TCZ hardly altered during chase periods up to 3 h. Furthennore, treatment of cells with TCZ did not affect the half-life of IL-6R-GFP, suggesting that PB-TCZ is internalized by the constitutive endocytosis of IL-6R-GFP.
I further examined the compartments where the internalized PB-TCZ was localized. The results
suggest that a part of the internalized PB-TCZ is either delivered from early endosomes to, and is degraded in, late endosomes/lysosomes in cells expressing IL-6R-GFP, without being significantly directed to the recycling pathway, while the remainder is retained in EEA I-positive early endosomes with IL-6R-GFP.
The cytoplasmic domain of IL-6R is necessary for its internalization
It has been shown that effective internalization of IL-6 and down-regulation of IL-6R are mediated by association with gpl30 (4). However, it remains unclear whether gpl 30 is involved in the internalization of PB-TCZ mediated by IL-6R. To this end, I knocked down the expression of gp 130 in HeLa cells by RNA interference. The depletion of gp 130 did not significantly influence the expression level and stability of IL-6R-GFP. Moreover, knock down of gp 130 did not significantly affect the internalization of PB-TCZ, or the localization of IL-6R-GFP. Therefore, these data apparently indicate that gp130 is not involved in the constitutive trafficking of IL-6R and concomitant internalization of PB-TCZ.
In the COOH-terminal cytoplasmic tail of IL-6R, consisting of 79 amino acids, there are two endocytosis motifs: a typical tyrosine-based type motif, 408 YSLG, and a dileucine-like motif, 427 LI ( Figure   2A ). Then, to examine whether the cytoplasmic tail of JL-6R including both tyrosine-and dileucine-based motifs is required for receptor internalization and trafficking, I created a mutant (IL-6R £l408-GFP) that deleted the COOH-terminal 60 amino acids including both motifs (Figure 2A) . In contrast to IL-6R WT-GFP expressing cells, most of the PB-TCZ stayed bound to the cell surface, and was scarcely internalized into cells expressing IL-6R £l408-GFP ( Figure 2B ). Thus, these data suggest that the cytoplasmic domain including tyrosine-and/or dileucine-like motifs is essential for effective internalization ofIL-6R. (B), Hela cells expressing IL-6R WT-GFP or IL-6R M08-GFP were preincubated with 2 µg/ml PB-TCZ at 4 °C for 30 min and immediately fixed or subsequently allowed to internalize the antibody for 30 min at 37°C. Cells were then visualized by confocal microscopy. Right columns show the merged images for double staining of IL-6R WT-GFP or IL-6R L'.408-GFP (green) and PB-TCZ (red). Bars, 20 µm.
Internalized PB-TCZ is sorted from JL-6R-GFP and escapes lysosoma/ degradation by the expression of FcRn-DsRed
One of the clinical problems associated with therapeutic monoclonal antibodies targeting particular antigens including TCZ is antigen-mediated clearance of antibodies from plasma (5 [CONCLUSION]
My results revealed that TCZ was internalized intracellularly via constitutive endocytosis taken by IL-6R, for which gp 130 was dispensable, and both receptor proteins were targeted to, and degraded in, lysosomes. Moreover, the cytoplasmic domain of IL-6R was required for the endocytosis and Jysosomal trafficking of the receptor and TCZ. I showed further that although FcRn was also transported to lysosomes, in contrast to IL-6R it was not significantly degraded. Since the steady-state localization of FcRn was predominantly restricted to early/recycling endosomes, these results suggest that FcRn undergoes rapid retrograde transport to these endosomes immediately after reaching lysosomes. Interestingly, expression of FcRn induced sorting of TCZ to the endosomal compartment from IL-6R-Jocalizing Jysosomal compartments. Based on these data, I propose a novel mechanism for the protection of IgG from degradation in which FcRn can retrieve IgG not only from endosomes, but also from lysosomes.
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